MPRX, Inc. dba Medical Park Pharmacy
FDA Regulatory Profile
Summary
- Total Recalls
- 18
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
| D-0816-2020 | Class II | Squaric Acid 0.1% Topical Solution (Clinic) 30 mL | December 18, 2019 |
| D-0809-2020 | Class II | Magic Bullet Supplement | December 18, 2019 |
| D-0818-2020 | Class II | Tadalafil 20 mg Troche | December 18, 2019 |
| D-0819-2020 | Class II | Tadalafil 6 mg Capsule | December 18, 2019 |
| D-0810-2020 | Class II | Naltrexone 4.5 mg capsule | December 18, 2019 |
| D-0817-2020 | Class II | T3/T4 SR 9 mcg/38 mcg capsule | December 18, 2019 |
| D-0813-2020 | Class II | Progesterone E4M SR 100 mg capsules | December 18, 2019 |
| D-0815-2020 | Class II | Sildenafil 80 mg capsules | December 18, 2019 |
| D-0811-2020 | Class II | Progesterone 200 mg Troche | December 18, 2019 |
| D-0804-2020 | Class II | Finasteride/Biotin 1 mg/50 mcg | December 18, 2019 |
| D-0814-2020 | Class II | Sildenafil 200 mg Troche (Clinic) | December 18, 2019 |
| D-0820-2020 | Class II | Testosterone Topical Cream 4% | December 18, 2019 |
| D-0806-2020 | Class II | Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars | December 18, 2019 |
| D-0808-2020 | Class II | Liothyronine (T3) 92.5 MCG | December 18, 2019 |
| D-0807-2020 | Class II | Liothyronine (T3) 80 mcg SR cap | December 18, 2019 |
| D-0805-2020 | Class II | Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars | December 18, 2019 |
| D-0812-2020 | Class II | Progesterone 50 mg capsules | December 18, 2019 |
| D-0803-2020 | Class II | DHEA/Pregnenol One 10.25 MG Cap | December 18, 2019 |